Navigation Links
World Debut for BSP's HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
Date:3/25/2008

TEL AVIV, Israel, March 25 /PRNewswire/ -- BSP Ltd. (http://www.bsp.co.il/pressall.asp), an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of ischemic heart disease, will be launching their HyperQ(TM) Stress System in the US during the 57th Annual ACC 08 Meeting in Chicago, IL.

The HyperQ(TM) is cutting-edge technology implemented in an innovative stress-test system, offering highly reliable, low-cost and risk free cardiac monitoring for broad populations and allows, for the first time, effective and accurate testing for Ischemic heart disease patients.

The HyperQ(TM) system received FDA clearance (510K), as well as the European CE marking. To date, more than 3500 patients in Israel, Europe and the US have been examined by HyperQ(TM) Stress Systems in controlled clinical studies, pilot programs and routine testing in the setting of private offices and hospital clinics. The results have demonstrated the system's high efficiency and unmatched accuracy in the diagnosis of IHD.

The company has entered the clinical and commercial phase, during which the HyperQ(TM) Stress System will be integrated in inpatient settings, outpatient cardiology departments, private doctor offices and major research centers.

Further applications on the company's scope, based on the same core technology, include bedside monitors for ischemic events; devices for cardiac home-care and telemedicine; periodic check-up systems, and the implementation of the HyperQ(TM) technology in implantable cardiac devices such as pacemakers and defibrillators.

Dr. Amir Beker, CEO of BSP says, "BSP's HyperQ(TM) technology is a revolutionary solution to today's most fatal pathology. The HyperQ(TM) Stress System is a non-invasive solution that will improve the standard of care for cardiac patients and at the same time will help reduce unnecessary costly and potentially harmful procedures. The HyperQ(TM) Stress System thus addresses dire needs of private and national healthcare systems to balance the immense costs of cardiac diagnosis and monitoring, while decreasing the risk of further, often invasive, tests for cardiac patients".

About BSP

BSP is dedicated to providing novel, risk free and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. BSP was founded in 2000 by Dr. Amir Beker and Mr. Ariel Landau and has completed a successful IPO in mid-2006 and its shares are traded on the Tel Aviv Stock Exchange.

Contact: Dr. Amir Beker, +972-3-6474840, http://www.bspmedical.com


'/>"/>
SOURCE BSP - Biological Signal Processing Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nanoscience will change the way we think about the world
2. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
4. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
5. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
6. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
7. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
8. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
9. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
10. World Glaucoma Day Set for March 6th
11. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Cynvenio Biosystems, Inc. a leader in personalized medicine technology and ... study in partnership with Allentown, PA-based TME Research . The multi-center registry study ... two years with Cynvenio’s ClearID Breast Cancer blood test. The study goal is to ...
(Date:4/27/2017)... ... April 27, 2017 , ... Oncolinx, a spin-out of ... Competition, has truly taken their cancer research out of this world. On April ... Cape Canaveral to the International Space Station’s (ISS) U.S. National Laboratory, managed by ...
(Date:4/27/2017)... ... 27, 2017 , ... Arrowhead Publishers is pleased to announce ... to San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, biotech, ... in the treatment of various types of pain. There are also extended networking ...
(Date:4/27/2017)... ... 27, 2017 , ... Volunteers supported by SPIE, the ... industry professionals in visiting U.S. Congressional offices in Washington, D.C., yesterday to urge ... industry. , This year, National Photonics Initiative (NPI) Congressional Visits Day ...
Breaking Biology Technology:
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):